Literature DB >> 6161884

Potentiation of natural killer activity of human lymphocytes by Staphylococcus aureus bacteria and its protein A.

T Kasahara, H Harada, K Shioiri-Nakano, M Imai, T Sano.   

Abstract

Cytotoxic activity of human lymphocytes against the myeloid cell line K-562 was augmented greatly by 24-h incubation with Staphylococcus aureus Cowan I bacteria (SpA CoI) and its protein A. This effect was not observed when these stimulants were added after preincubation, suggesting that this activity was different from so-called lectin-induced cellular cytotoxicity. Potentiation required at least 12 to 18 h incubation of lymphocytes with these stimulants. Macrophage depletion did not affect the potentiation by protein A or SpA coI, although the potentiation by poly I:C or OK-432, an immunopotentiator of Streptococcus pyogenes was completely reduced. Further cell separation procedures revealed that neither T cells nor FcR- cells, which showed little natural killer (NK) activity, were enhanced by protein A or SpA coI. On the other hand, (a) null cells which were obtained from nylon column (NC)-passed fraction by depleting T cells and surface membrane Ig-positive cells, and (b) FcR+ E- cells which were obtained from NC-passed fraction by depleting FcR- cells and T cells, showed marked NK activity by themselves and were further augmented by these stimulants. FcR+ E+ cells failed to show NK activity even if they were stimulated by these stimulants. Thus, it was found that protein A and SpA CoI, as well as human interferon, could stimulate NC-non-adherent, FcR+, E- NK cells and potentiate markedly their NK activity.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6161884      PMCID: PMC1458081     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  25 in total

1.  The effector cells in human peripheral blood mediating mitogen-induced cellular cytotoxicity and antibody-dependent cellular cytotoxicity.

Authors:  D L Nelson; B M Bundy; H E Pitchon; R M Blaese; W Strober
Journal:  J Immunol       Date:  1976-11       Impact factor: 5.422

Review 2.  Mouse natural killer cells: induction specificity, and function.

Authors:  R M Welsh
Journal:  J Immunol       Date:  1978-11       Impact factor: 5.422

3.  Studies on the mechanism of lymphocyte-mediated cytolysis. XI. The role of lectin in lectin-dependent cell-mediated cytotoxicity.

Authors:  W R Green; Z K Ballas; C S Henney
Journal:  J Immunol       Date:  1978-10       Impact factor: 5.422

4.  Comparison of the direct antiglobulin rosetting reaction with direct immunofluorescence in the detection of surface membrane immunoglobulin on human peripheral blood lymphocytes.

Authors:  D G Haegert; C Hurd; R R Coombs
Journal:  Immunology       Date:  1978-03       Impact factor: 7.397

5.  Enhanced NK cell activity in mice injected with interferon and interferon inducers.

Authors:  M Gidlund; A Orn; H Wigzell; A Senik; I Gresser
Journal:  Nature       Date:  1978-06-29       Impact factor: 49.962

6.  Lymphocyte-mediated cytotoxicity against human allogeneic and autologous lymphoid targets after concanavalin A-activation of cytotoxic effector cells.

Authors:  G W Hunninghake; A S Fauci
Journal:  J Immunol       Date:  1977-09       Impact factor: 5.422

7.  Spontaneous cell-mediated cytotoxicity in humans: role of interferon and immunoglobulins.

Authors:  G Trinchieri; D Santoli; H Koprowski
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

8.  Role of non-conventional natural killer cells in resistance against syngeneic tumour cells in vivo.

Authors:  O Haller; M Hansson; R Kiessling; H Wigzell
Journal:  Nature       Date:  1977-12-15       Impact factor: 49.962

9.  BCG-induced murine effector cells. II. Characterization of natural killer cells in peritoneal exudates.

Authors:  S A Wolfe; D E Tracey; C S Henney
Journal:  J Immunol       Date:  1977-09       Impact factor: 5.422

10.  Augmentation of natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic target cells.

Authors:  R B Herberman; M E Nunn; H T Holden; S Staal; J Y Djeu
Journal:  Int J Cancer       Date:  1977-04-15       Impact factor: 7.396

View more
  7 in total

1.  Intact natural killer activity in glycogenosis type Ib.

Authors:  T Hara; E Ishii; K Ohkubo; K Ueda
Journal:  Eur J Pediatr       Date:  1986-08       Impact factor: 3.183

2.  Effects of anti-Tac antibody on the response of large granular lymphocytes to interleukin-2.

Authors:  N Mukaida; T Kasahara; J Hosoi; K Shioiri-Nakano; T Kawai
Journal:  Immunology       Date:  1986-01       Impact factor: 7.397

3.  The effects of staphylococcal protein A on human lymphokine-activated killer cell induction.

Authors:  R A Lindemann; K P Singh; H Shau; R K Gupta
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

4.  The Fc Domain of Immunoglobulin Is Sufficient to Bridge NK Cells with Virally Infected Cells.

Authors:  Hong-Sheng Dai; Nathaniel Griffin; Chelsea Bolyard; Hsiaoyin Charlene Mao; Jianying Zhang; Timothy P Cripe; Tadahiro Suenaga; Hisashi Arase; Ichiro Nakano; E A Chiocca; Balveen Kaur; Jianhua Yu; Michael A Caligiuri
Journal:  Immunity       Date:  2017-07-18       Impact factor: 31.745

5.  Regulation of natural and antibody-dependent cellular cytotoxicity by staphylococcal enterotoxin A.

Authors:  I Kimber; T Bakács; M Moore
Journal:  Clin Exp Immunol       Date:  1983-10       Impact factor: 4.330

6.  Effect of Staphylococcus aureus Cowan i bacteria on the mitogenic response of human B-cell subsets.

Authors:  H Harada; T Kasahara; K Ogata; K Shioiri-Nakano; T Kawai
Journal:  Immunology       Date:  1982-11       Impact factor: 7.397

7.  Potentiation of natural killer cell activity of human lymphocytes in vitro: the participation of interferon in stimulation with Staphylococcus aureus Cowan I bacteria but not with protein A.

Authors:  T Kasahara; H Harada; K Shioiri-Nakano; H Wakasugi; M Imai; M Mayumi; T Sano; A Sugiura
Journal:  Immunology       Date:  1982-04       Impact factor: 7.397

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.